Inside Precision Medicine·4 min read·hard
Blood Test Foresees Decline into Alzheimer’s Disease
A
Anita Chakraverty
✦AI Summary
Researchers have identified a blood-based biomarker, p-tau217, that can predict the risk of Alzheimer's disease years before symptoms appear. The study suggests this could enable earlier intervention and better clinical trial design.
A blood-based biomarker could predict a person’s risk of developing Alzheimer’s disease years before any symptoms arise, research suggests.
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in